Regulation of the synthesis of plasminogen activator inhibitor type 1 (PAI-1): pathogenetic mechanism of atherosclerosis in diabetes mellitus?

被引:3
作者
Nordt, TK
Peter, K
Kubler, W
Bode, C
机构
来源
FIBRINOLYSIS & PROTEOLYSIS | 1997年 / 11卷
关键词
D O I
10.1016/S0268-9499(97)80088-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:141 / 147
页数:7
相关论文
共 75 条
  • [1] ALESSI MC, 1988, THROMB HAEMOSTASIS, V60, P491
  • [2] MAJOR CIRCADIAN FLUCTUATIONS IN FIBRINOLYTIC FACTORS AND POSSIBLE RELEVANCE TO TIME OF ONSET OF MYOCARDIAL-INFARCTION, SUDDEN CARDIAC DEATH AND STROKE
    ANDREOTTI, F
    DAVIES, GJ
    HACKETT, DR
    KHAN, MI
    DEBART, ACW
    ABER, VR
    MASERI, A
    KLUFT, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (09) : 635 - 637
  • [3] DIURNAL-VARIATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RAPID INHIBITOR (PAI-1)
    ANGLETON, P
    CHANDLER, WL
    SCHMER, G
    [J]. CIRCULATION, 1989, 79 (01) : 101 - 106
  • [4] AZNAR J, 1988, BRIT HEART J, V59, P535
  • [5] CORRELATION OF BASELINE PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY WITH PATENCY OF THE INFARCT ARTERY AFTER THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION
    BARBASH, GI
    HOD, H
    ROTH, A
    MILLER, HI
    RATH, S
    ZAHAV, YH
    MODAN, M
    ZIVELIN, A
    LANIADO, S
    SELIGSOHN, U
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (19) : 1231 - 1235
  • [6] ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS
    BERLINER, JA
    NAVAB, M
    FOGELMAN, AM
    FRANK, JS
    DEMER, LL
    EDWARDS, PA
    WATSON, AD
    LUSIS, AJ
    [J]. CIRCULATION, 1995, 91 (09) : 2488 - 2496
  • [7] IDENTIFICATION AND DISTRIBUTION OF FIBRINOGEN, FIBRIN, AND FIBRIN(OGEN) DEGRADATION PRODUCTS IN ATHEROSCLEROSIS - USE OF MONOCLONAL-ANTIBODIES
    BINI, A
    FENOGLIO, JJ
    MESATEJADA, R
    KUDRYK, B
    KAPLAN, KL
    [J]. ARTERIOSCLEROSIS, 1989, 9 (01): : 109 - 121
  • [8] A RAPID AND SENSITIVE RADIOIMMUNOASSAY FOR THE MEASUREMENT OF PROINSULIN IN HUMAN SERUM
    BOWSHER, RR
    WOLNY, JD
    FRANK, BH
    [J]. DIABETES, 1992, 41 (09) : 1084 - 1090
  • [9] *BYP ANG REV INV, 1996, NEW ENGL J MED, V335, P217
  • [10] CAGLIERO E, 1991, J BIOL CHEM, V266, P14244